SAN JOSE, Calif. and SALT LAKE CITY, Sept. 21, 2022 (GLOBE NEWSWIRE) — BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions and bioMérieux, a world leader in the field of in vitro diagnostics, announced today a partnership to develop and bring to market a Clinical Digital Solution for diagnostics enabling clinical decision support for disease areas across their diagnostic tests.

Read more here.